KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Share-based Compensation (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.77%
Dec 31, 2025 -4.32%
Sep 30, 2025 1.46%
Jun 30, 2025 -4.86%
Mar 31, 2025 20.00%
Dec 31, 2024 -6.98%
Sep 30, 2024 3.20%
Jun 30, 2024 -6.02%
Mar 31, 2024 4.72%
Dec 31, 2023 -3.79%
Sep 30, 2023 -3.65%
Jun 30, 2023 12.30%
Mar 31, 2023 2.52%
Dec 31, 2022 3.48%
Sep 30, 2022 -0.86%
Jun 30, 2022 8.41%
Mar 31, 2022 -19.55%
Dec 31, 2021 -6.34%
Sep 30, 2021 -9.55%
Jun 30, 2021 3.97%
Mar 31, 2021 -11.70%
Dec 31, 2020 -7.57%
Sep 30, 2020 -13.15%
Jun 30, 2020 1.43%
Mar 31, 2020 -26.06%
Dec 31, 2019 407.14%
Sep 30, 2019 16.67%
Jun 30, 2019 -9.43%
Mar 31, 2019 0.00%
Dec 31, 2018 -14.52%
Sep 30, 2018 21.57%
Jun 30, 2018 -7.27%
Mar 31, 2018 10.00%
Dec 31, 2017 0.00%
Sep 30, 2017 -7.41%
Jun 30, 2017 20.00%
Mar 31, 2017 -19.64%
Dec 31, 2016 16.67%
Sep 30, 2016 -11.11%
Jun 30, 2016 14.89%
Mar 31, 2016 -20.34%
Dec 31, 2015 -6.35%
Sep 30, 2015 6.78%
Jun 30, 2015 9.26%
Mar 31, 2015 -18.18%
Dec 31, 2014 37.50%
Sep 30, 2014 -4.00%
Jun 30, 2014 2.04%
Mar 31, 2014 -3.92%
Dec 31, 2013 13.33%
Sep 30, 2013 -2.17%
Jun 30, 2013 -6.12%
Mar 31, 2013 6.52%
Dec 31, 2012 -61.67%
Sep 30, 2012 200.00%
Jun 30, 2012 -4.76%
Mar 31, 2012 2.44%
Dec 31, 2011 5.13%
Sep 30, 2011 -9.30%
Jun 30, 2011 13.16%
Mar 31, 2011 -24.00%
Dec 31, 2010 6.38%
Sep 30, 2010 -4.08%
Jun 30, 2010 4.26%
Mar 31, 2010 -11.32%
Dec 31, 2009 26.19%